Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Reiser

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Immunology Research|June 18, 2016
Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune ResponseJohn Reiser, Arnob Banerjee
Cellular Immunology|December 12, 2018
Eomesodermin driven IL-10 production in effector CD8<sup>+</sup> T cells promotes a memory phenotypeJohn Reiser, Kavitha Sadashivaiah, Aki Furusawa, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 23, 2017
Eomesodermin Increases Survival and IL-2 Responsiveness of Tumor-specific CD8+ T Cells in an Adoptive Transfer Model of Cancer ImmunotherapyAki Furusawa, John Reiser, Kavitha Sadashivaiah, et al.
Frontiers in Immunology|July 9, 2024
CXCR4 has a dual role in improving the efficacy of BCMA-redirected CAR-NK cells in multiple myelomaMichael W Moles, Henry Erdlei, Lutz Menzel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2025
Bispecific BAFF-R/BCMA CAR T cells control growth of heterogeneous plasma cells in multiple myelomaAgnese Fiori, Karin Zimmermann, Anna Li, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Immunology Research|June 18, 2016
Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune ResponseJohn Reiser, Arnob Banerjee
Cellular Immunology|December 12, 2018
Eomesodermin driven IL-10 production in effector CD8<sup>+</sup> T cells promotes a memory phenotypeJohn Reiser, Kavitha Sadashivaiah, Aki Furusawa, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 23, 2017
Eomesodermin Increases Survival and IL-2 Responsiveness of Tumor-specific CD8+ T Cells in an Adoptive Transfer Model of Cancer ImmunotherapyAki Furusawa, John Reiser, Kavitha Sadashivaiah, et al.
Frontiers in Immunology|July 9, 2024
CXCR4 has a dual role in improving the efficacy of BCMA-redirected CAR-NK cells in multiple myelomaMichael W Moles, Henry Erdlei, Lutz Menzel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2025
Bispecific BAFF-R/BCMA CAR T cells control growth of heterogeneous plasma cells in multiple myelomaAgnese Fiori, Karin Zimmermann, Anna Li, et al.
Pageof 1